Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib

被引：14
|
作者：
Yagi, Kumi [1 ]
Ishida, Yoshihiro [1 ]
Otsuka, Atsushi [1 ]
Kabashima, Kenji [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2021年 / 62卷 / 03期
关键词：
D O I：
10.1111/ajd.13572
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：433 / +
页数：2
相关论文
共 50 条
  • [1] Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
    Rothstein, Brooke
    Joshipura, Deep
    Saraiya, Ami
    Abdat, Rana
    Ashkar, Huda
    Turkowski, Yana
    Sheth, Vaneeta
    Huang, Victor
    Au, Shiu Chung
    Kachuk, Courtney
    Dumont, Nicole
    Gottlieb, Alice B.
    Rosmarin, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1054 - +
  • [2] Treatment of vitiligo with topical janus kinase inhibitor ruxolitinib
    Rothstein, B.
    Joshipura, D.
    Saraiya, A.
    Abdat, R.
    Ashkar, H.
    Turkowski, Y.
    Sheth, V.
    Huang, V.
    Au, S. Chung
    Kachuk, C.
    Dumont, N.
    Gottlieb, A. B.
    Rosmarin, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S132 - S132
  • [3] Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
    Berbert Ferreira, Sineida
    Berbert Ferreira, Rachel
    Neves Neto, Afonso Cesar
    Assef, Silvana Martins Caparroz
    Scheinberg, Morton
    CASE REPORTS IN DERMATOLOGY, 2021, 13 (01): : 190 - 194
  • [4] Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Murata, Ryusei
    Kaino, Hironobu
    Nagata, Takeshi
    JOURNAL OF DERMATOLOGY, 2020, 47 (02): : 114 - 120
  • [5] Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review
    Abduelmula, Abrahim
    Mufti, Asfandyar
    Chong, Derrick HY.
    Sood, Siddhartha
    Sachdeva, Muskaan
    Yeung, Jensen
    JAAD INTERNATIONAL, 2022, 9 : 156 - 158
  • [6] Progressive vitiligo in adults treated with Janus kinase inhibitor tofacitinib: An open label study
    AlMutairi, Nawaf
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB109 - AB109
  • [7] Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model
    Yamamoto, Yasuo
    Otsuka, Atsushi
    Nakashima, Chisa
    Ishida, Yoshihiro
    Honda, Tetsuya
    Egawa, Gyohei
    Amano, Wataru
    Usui, Kenji
    Hamada, Yuji
    Wada, Masashi
    Tanimoto, Atsuo
    Konishi, Noriko
    Hayashi, Mikio
    Matsushita, Mutsuyoshi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 97 (02) : 161 - 164
  • [8] Remission of Severe Eyelid Dermatitis With a Topical Janus Kinase Inhibitor
    Peterson, Danielle
    King, Brett
    DERMATITIS, 2021, 32 (1S) : E98 - E99
  • [9] This Month in JAAD International: December 2022: Topical management of vitiligo with Janus kinase inhibitors
    Kantor, Jonathan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (06) : 1284 - 1284
  • [10] Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review
    Sood, Siddhartha
    Varenbut, Jaymie
    Bagit, Ahmed
    Perlmutter, Jonah
    Maliyar, Khalad
    Sachdeva, Muskaan
    Abduelmula, Abrahim
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Prajapati, Vimal H.
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 135 - 137
12345